Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care

PRINCETON, NJ – Sept. 26, 2018 – Certara announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients.

Read More
Topics:

Clinical Pharmacology Gap Analysis: Your FAQs

Julie Bullock

As drug development has become more complex, with a higher risk of failure, greater uncertainty, and increased expense, the need for a quantitative and regulatory science-based strategy becomes clear. The first step in that performing that strategic assessment is a gap analysis and roadmap. Over the last couple of months, I’ve written a series of blog […]

Read More
Topics: Clinical Pharmacology Strategy, PBPK Modeling & Simulation

Clinical Pharmacology Gap Analysis: Lessons Learned

Julie Bullock

Clinical pharmacology gap analysis is a tool for outlining your drug program’s needs, prioritizing these needs, and providing a framework for how to satisfy them. This tool can create value for drug development programs. While gap analysis can be performed at any point in the drug development continuum, early engagement is best for maximizing its benefits. […]

Read More
Topics: Clinical Pharmacology Strategy, PBPK Modeling & Simulation, PK/PD Modeling & Simulation

Application of Tracer Kinetics in Drug Development: A Valuable but Underused Tool in Clinical Pharmacology

In this webinar, Pau Aceves, Associate Director of Consulting Services at Certara, presented case studies on how tracer kinetics were used to inform development of new drugs for lung, CNS, and liver diseases. By watching this webinar, you will learn how tracer kinetics can leveraged for PK, PD, and in silico modeling applications.

Read More
Topics:

PK/TK Services

Pre-clinical Pharmacokinetic/Toxicokinetic NCA Services Navigating pre-clinical regulatory safety assessments for drug candidate selection is a crucial step in the drug discovery and development process that requires extensive PK and TK expertise. Certara’s comprehensive PK/TK services offering integrates proven and extensive pre-clinical expertise with advanced modeling and simulation approaches using Phoenix WinNonlin®, the trusted industry standard […]

Read More
Topics:
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog